dexfenfluramine has been researched along with Encephalopathy, Toxic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foreyt, JP; Poston, WS | 1 |
| Laverty, R; Russell, BR | 1 |
1 review(s) available for dexfenfluramine and Encephalopathy, Toxic
| Article | Year |
|---|---|
Scientific and legal issues in fenfluramine/dexfenfluramine litigation.
Topics: Anti-Obesity Agents; Dexfenfluramine; Fenfluramine; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Legislation, Medical; Neurotoxicity Syndromes; Risk Assessment; Science; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Weight Loss | 2000 |
1 other study(ies) available for dexfenfluramine and Encephalopathy, Toxic
| Article | Year |
|---|---|
The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity.
Topics: Animals; Autoradiography; Body Temperature; Brain Chemistry; Carrier Proteins; Chromatography, High Pressure Liquid; Dexfenfluramine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurotoxicity Syndromes; Pyrrolidinones; Quinoxalines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Serotonin; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Stereoisomerism; Telemetry | 2001 |